PIIND2023-01-012023-03-31 PIIND2023-01-012023-03-31 PIIND2023-01-012023-03-31in-bse-fin:OneOperatingExpenses01Member PIIND2023-01-012023-03-31in-bse-fin:OneOperatingExpenses02Member PIIND2023-01-012023-03-31in-bse-fin:OneOperatingExpenses03Member PIIND2023-01-012023-03-31in-bse-fin:OneOperatingExpenses04Member PIIND2023-01-012023-03-31in-bse-fin:OneOperatingExpenses05Member PIIND2023-01-012023-03-31in-bse-fin:OneOperatingExpenses06Member PIIND2023-01-012023-03-31in-bse-fin:OneOperatingExpenses07Member PIIND2023-01-012023-03-31in-bse-fin:OneOperatingExpenses08Member PIIND2023-01-012023-03-31in-bse-fin:OneOperatingExpenses09Member PIIND2023-01-012023-03-31in-bse-fin:OneOperatingExpenses10Member PIIND2023-01-012023-03-31in-bse-fin:FourOperatingExpenses01Member PIIND2023-01-012023-03-31in-bse-fin:FourOperatingExpenses02Member PIIND2023-01-012023-03-31in-bse-fin:FourOperatingExpenses03Member PIIND2023-01-012023-03-31in-bse-fin:FourOperatingExpenses04Member PIIND2023-01-012023-03-31in-bse-fin:FourOperatingExpenses05Member PIIND2023-01-012023-03-31in-bse-fin:FourOperatingExpenses06Member PIIND2023-01-012023-03-31in-bse-fin:FourOperatingExpenses07Member PIIND2023-01-012023-03-31in-bse-fin:FourOperatingExpenses08Member PIIND2023-01-012023-03-31in-bse-fin:FourOperatingExpenses09Member PIIND2023-01-012023-03-31in-bse-fin:FourOperatingExpenses10Member PIIND2023-03-31 PIIND2023-01-012023-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PIIND2023-01-012023-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PIIND2023-01-012023-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PIIND2023-01-012023-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 523642 PIIND NOTLISTED PI Industries Limited Equity 2022-04-01 2023-03-31 2023-05-18 2023-05-11 INR Millions Yearly 14:30:00 20:25:00 2023-05-18 2023-05-18 true Cash Flow Indirect Declaration of unmodified opinion Single segment Agri 2023-01-01 2023-03-31 Audited Standalone 15064000000.00 526000000.00 15590000000.00 8283000000.00 299000000.00 -311000000.00 1253000000.00 25000000.00 561000000.00 2197000000.00 12307000000.00 3283000000.00 0.00 3283000000.00 586000000.00 -97000000.00 489000000.00 0.00 2794000000.00 0.00 0.00 0.00 0.00 2794000000.00 131000000.00 2925000000.00 2925000000.00 0.00 152000000.00 1 18.41 18.41 0.00 0.00 18.41 18.41 a. The above financial results were reviewed and recommended by the Audit Committee of the Board and approved by the Board of Directors at their meeting held on May 18, 2023. b. Financial results for all the periods presented have been prepared in accordance with the recognition and measurement principles of lnd AS notified under the Companies (Indian Accounting Standards) Rules, 2015. c. The figures for the March quarter are the balancing figures between audited figures in respect of full financial year and the published unaudited year to date figures up to the th ird quarter of the respective financial year. d. The Company is in the business of manufacturing and distribution of Agro Chemicals and accordingly has one reportable business segment viz. Agro Chemicals. e. The Company has raised Rs.20,000 million during the quarter ended 30th September 2020 through Qualified Institutional Placement (QIP) of equity shares. Out of the funds received of Rs.19,750 million (net of expense of Rs.250 million), the Company has invested Rs.865 million during the year, in one of its subsidiary PI Health Sciences Limited to commence its business operations. Balance funds of Rs.18,885 million received pursuant to QIP remain invested in fixed deposits, liquid and other debt mutual funds. f. Events subsequent to Balance sheet date:- a) PI Health Sciences Ltd has entered into a share purchase agreement dated 27th April 2023 for the acquisition of 100% shareholding of Therachem Research Medilab (India) Private Limited and Solis Pharmachem Private Limited . Further, PI Health Sciences USA, LLC has entered into an asset purchase agreement dated 27th April 2023 for the acquisition of certain identified assets of Therachem Research Medilab LLC, USA. These agreements are subject to satisfactory completion of conditions precedents as set out in the respective agreement. b) PI Health Sciences Netherlands BV has entered into a share purchase agreement dated 26th April 2023 for the acquisition of 100% shareholding of Archimica S.p.A, Italy and acquired 100% shares on 27th April 2023. There is no impact of these transactions on the financial statements as at March 31, 2023. g. The previous period's figures have been regrouped/ rearranged/ reclassified wherever necessary. h. Standalone Statement of Cash flows is attached in Annexure I. i. The Board of Directors at their meeting held on May 18, 2023 have recommended a final dividend of Rs.5.50 per equityshare, subject to the approval of the shareholders in th e ensuring Annual General Meeting. With this, total dividend for the year (including interim dividend of Rs.4.50 per equity share paid during the year) is Rs.10 per share. Single segment 2022-04-01 2023-03-31 Audited Standalone 62704000000.00 1589000000.00 64293000000.00 33550000000.00 1566000000.00 -941000000.00 4897000000.00 355000000.00 2217000000.00 8432000000.00 50076000000.00 14217000000.00 0.00 14217000000.00 2567000000.00 -464000000.00 2103000000.00 0.00 12114000000.00 0.00 0.00 0.00 0.00 12114000000.00 -396000000.00 11718000000.00 11718000000.00 0.00 152000000.00 1 70816000000.00 79.84 79.84 0.00 0.00 79.84 79.84 Advertisement & Sales Promotion 121000000.00 Environment & Pollution Control expenses 247000000.00 Freight & Cartage 152000000.00 Legal & professional fees 142000000.00 Others 643000000.00 Power, Fuel & Water 501000000.00 Provision for Bad and Doubtful debts & Advances -22000000.00 Repairs & Maintenance - Others 95000000.00 Repairs & Maintenance - Plant and machinery 130000000.00 Travelling and conveyance 188000000.00 Advertisement & Sales Promotion 614000000.00 Environment & Pollution Control expenses 1070000000.00 Freight & Cartage 825000000.00 Legal & professional fees 388000000.00 Others 2144000000.00 Power, Fuel & Water 1900000000.00 Provision for Bad and Doubtful debts & Advances 111000000.00 Repairs & Maintenance - Others 300000000.00 Repairs & Maintenance - Plant and machinery 473000000.00 Travelling and conveyance 607000000.00 24174000000.00 609000000.00 0.00 671000000.00 283000000.00 690000000.00 0.00 0.00 1845000000.00 0.00 690000000.00 157000000.00 2692000000.00 0.00 134000000.00 29253000000.00 13447000000.00 9843000000.00 7595000000.00 8047000000.00 13276000000.00 137000000.00 17000000.00 38915000000.00 0.00 1743000000.00 54105000000.00 0.00 0.00 83358000000.00 152000000.00 70816000000.00 70968000000.00 70968000000.00 0.00 0.00 491000000.00 491000000.00 90000000.00 287000000.00 0.00 0.00 868000000.00 0.00 8360000000.00 2187000000.00 10547000000.00 645000000.00 276000000.00 54000000.00 0.00 11522000000.00 0.00 0.00 12390000000.00 83358000000.00 355000000.00 -126000000.00 1134000000.00 0.00 1104000000.00 1000000.00 -722000000.00 723000000.00 67000000.00 -271000000.00 0.00 10000000.00 0.00 2217000000.00 0.00 0.00 34000000.00 175000000.00 55000000.00 -353000000.00 0.00 818000000.00 0.00 -354000000.00 0.00 0.00 0.00 44000000.00 0.00 3275000000.00 17492000000.00 0.00 0.00 0.00 2471000000.00 0.00 15021000000.00 0.00 0.00 0.00 -235000000.00 0.00 0.00 0.00 0.00 38000000.00 3049000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 818000000.00 0.00 -3336000000.00 0.00 -5294000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2669000000.00 0.00 0.00 0.00 1137000000.00 325000000.00 0.00 -174000000.00 -4305000000.00 5422000000.00 0.00 5422000000.00 3095000000.00 8517000000.00 Remeasurement gains/(loss) on defined benefits plans 37000000.00 Remeasurement gains/(loss) on defined benefits plans 28000000.00 37000000.00 28000000.00 13000000.00 10000000.00 Effective portion of gains/(losses) on cash flow hedges 165000000.00 Effective portion of gains/(losses) on cash flow hedges -636000000.00 165000000.00 -636000000.00 58000000.00 -222000000.00